Carilee Berg

  • Citations Per Year
Learn More
NATURE REVIEWS | DRUG DISCOVERY VOLUME 1 | NOVEMBER 2002 | 845 Twenty years ago, the commercial launch of recombinant insulin, the first biotechnologyderived drug, marked the birth of biotech. Today, biotech is coming into its own as a mature industry, although its growing pains are exacerbated by the current economic climate. Here, we take a look at how(More)
Teriparatide (Forteo; Eli Lilly), a recombinant form of the 34 amino-terminal amino acids of human parathyroid hormone, was approved by the US FDA in November 2002 for the treatment of osteoporosis. As the first agent to stimulate bone formation, rather than just reduce bone loss, what impact is it likely to have on the osteoporosis drug market?
  • 1